Fujifilm deepens its CMO heft with Kalon buyout

Fujifilm has completed its acquisition of Kalon Biotherapeutics, a contract manufacturer with a focus on vaccines. The Japanese company acquired a stake in Kalon back in October and is now closing the gap with plans to integrate the company into its Diosynth unit. Story

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

Genae's CEO says the transaction reflects recent focus on digital health and data-driven services.